United States Active Pharmaceutical Ingredients (API) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The United States Active Pharmaceutical Ingredients (API) Market is Segmented by Business Mode (Captive API and Merchant API), Synthesis Type (Synthetic and Biotech), Drug Type (Generic and Branded), and Application (Cardiology, Oncology, Pulmonology, Neurology, Orthopedic, Ophthalmology, and Other Applications). The report offers the value (in USD billion) for the above segments.

United States Active Pharmaceutical Ingredients (API) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

US Active Pharmaceutical Ingredients (API) Industry Overview

The United States Active Pharmaceutical Ingredients market is relatively fragmented. The API market has several manufacturers focusing on expanding their footprints by adopting various business strategies, such as collaborations, facility expansion, and drug approvals. Some of the companies in the market are Pfizer Inc., Novartis AG, BASF SE, Viatris Inc., Lupin Ltd, Teva Pharmaceutical Industries Ltd, and Merck KGaA, among others.

US Active Pharmaceutical Ingredients (API) Market Leaders

  1. Pfizer Inc.

  2. Novartis AG

  3. BASF SE

  4. Viatris Inc.

  5. Teva Pharmaceutical Industries Ltd

  6. *Disclaimer: Major Players sorted in no particular order
United States Active Pharmaceutical Ingredients Market - cl.png

United States Active Pharmaceutical Ingredients (API) Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?